Brookfield Asset Management Inc. Penumbra Inc Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$220.43 - $278.69 $776,574 - $981,824	3,523 New	3,523 $981,000
Q1 2023 May 15, 2023	SELL	$220.43 - $278.69 $2.76 Million - $3.49 Million	-12,535 Reduced 78.06%	3,523 $981,000
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $494,825 - $744,453	3,258 Added 25.45%	16,058 $3.57 Million
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $1.54 Million - $2.64 Million	12,800 New	12,800 $2.43 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.